CXCL10 and neoplasm: Similarly, murine-leukemia virus (MLV)-derived replication-competent retroviruses were used to stably express CXCL10 in fibrosarcoma, melanoma and Lewis lung cancer models and were shown to inhibit tumor growth in vivo (65).